AEON BIOPHARMA INC (AEON) Stock Analyst Ratings
USA - NYSEARCA:AEON - US00791X2099 - Common Stock
0.91 USD
-0.03 (-3.19%)
0.88 USD
-0.03 (-3.3%)
ChartMill assigns a Buy % Consensus number of 83% to AEON. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.34. This target is 707.03% above the current price.
AEON was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about AEON.
In the previous month the buy percentage consensus was at a similar level.
AEON was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-08 | Aegis Capital | Reiterate | Buy -> Buy |
| 2024-10-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-07-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-18 | HC Wainwright & Co. | Initiate | Buy |
AEON BIOPHARMA INC / AEON FAQ
What do analysts expect the price target to be for AEON BIOPHARMA INC (AEON)?
7 analysts have analysed AEON and the average price target is 7.34 USD. This implies a price increase of 707.03% is expected in the next year compared to the current price of 0.91.
Can you provide the consensus rating for AEON BIOPHARMA INC stock?
The consensus rating for AEON BIOPHARMA INC (AEON) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.